ONCSQ (OncoSec Medical) Research & Development: $21.77 Mil (TTM As of Jan. 2023)


What is OncoSec Medical Research & Development?

OncoSec Medical ONCSQ -99.00% Research & Development is $21.77 Mil as of Jan. 2023.

Research & Development is the aggregate amount of research and development expenses during the year. OncoSec Medical's Research & Development for the three months ended in Jan. 2023 was $4.65 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jan. 2023 was $21.77 Mil.

OncoSec Medical  (OTCPK:ONCSQ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

OncoSec Medical Research & Development Related Terms

OncoSec Medical Research & Development Historical Data

* Premium members only.

The historical data trend for OncoSec Medical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoSec Medical Research & Development Chart

OncoSec Medical Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.42 18.45 25.10 34.10 25.82

OncoSec Medical Quarterly Data
Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.83 7.03 5.32 4.77 4.65

OncoSec Medical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jan. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $21.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $21.77 Mil mean?
OncoSec Medical (ONCSQ) has a Research & Development of $21.77 Mil as of Jan. 2023. Research and development expense is the total cost for research and development activities. View historical data on OncoSec Medical and its competitors.
Is OncoSec Medical's Research & Development too high?
OncoSec Medical's current Research & Development is $21.77 Mil.
How does OncoSec Medical's Research & Development compare to NOVNQ and USRM?
OncoSec Medical's Research & Development of $21.77 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on OncoSec Medical and its competitors. OncoSec Medical's current Research & Development is $21.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoSec Medical stock overvalued right now?
OncoSec Medical (ONCSQ) has a current Research & Development of $21.77 Mil. The current Research & Development is $21.77 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For OncoSec Medical (ONCSQ), the current Research & Development is $21.77 Mil as of Jan. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoSec Medical Business Description

Address 820 Bear Tavern Road, Ewing, NJ, USA, 08628-1021
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.